Corinna Glasner
University Medical Center Groningen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Corinna Glasner.
Eurosurveillance | 2013
Corinna Glasner; Barbara Albiger; Girbe Buist; A. Tambić Andrašević; Rafael Cantón; Yehuda Carmeli; Alexander W. Friedrich; Christian G. Giske; Youri Glupczynski; Marek Gniadkowski; David M. Livermore; Patrice Nordmann; Laurent Poirel; Gian Maria Rossolini; Harald Seifert; Alkiviadis Vatopoulos; Timothy R. Walsh; Neil Woodford; Tjibbe Donker; Dominique L. Monnet; Hajo Grundmann
The spread of carbapenemase-producing Enterobacteriaceae (CPE) is a threat to healthcare delivery, although its extent differs substantially from country to country. In February 2013, national experts from 39 European countries were invited to self-assess the current epidemiological situation of CPE in their country. Information about national management of CPE was also reported. The results highlight the urgent need for a coordinated European effort on early diagnosis, active surveillance, and guidance on infection control measures.
Lancet Infectious Diseases | 2017
Hajo Grundmann; Corinna Glasner; Barbara Albiger; David M. Aanensen; Chris T Tomlinson; Arjana Tambić Andrasević; Rafael Cantón; Yehuda Carmeli; Alexander W. Friedrich; Christian G. Giske; Youri Glupczynski; Marek Gniadkowski; David M. Livermore; Patrice Nordmann; Laurent Poirel; Gian Maria Rossolini; Harald Seifert; Alkiviadis Vatopoulos; Timothy R. Walsh; Neil Woodford; Dominique L. Monnet; Andi Koraqi; Denada Lacej; Petra Apfalter; Rainer Hartl; Te-Din Huang; Tanya Strateva; Yuliya Marteva-Proevska; Iva Butic; Despo Pieridou-Bagatzouni
BACKGROUND Gaps in the diagnostic capacity and heterogeneity of national surveillance and reporting standards in Europe make it difficult to contain carbapenemase-producing Enterobacteriaceae. We report the development of a consistent sampling framework and the results of the first structured survey on the occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in European hospitals. METHODS National expert laboratories recruited hospitals with diagnostic capacities, who collected the first ten carbapenem non-susceptible clinical isolates of K pneumoniae or E coli and ten susceptible same-species comparator isolates and pertinent patient and hospital information. Isolates and data were relayed back to national expert laboratories, which made laboratory-substantiated information available for central analysis. FINDINGS Between Nov 1, 2013, and April 30, 2014, 455 sentinel hospitals in 36 countries submitted 2703 clinical isolates (2301 [85%] K pneumoniae and 402 (15%) E coli). 850 (37%) of 2301 K pneumoniae samples and 77 (19%) of 402 E coli samples were carbapenemase (KPC, NDM, OXA-48-like, or VIM) producers. The ratio of K pneumoniae to E coli was 11:1. 1·3 patients per 10 000 hospital admissions had positive clinical specimens. Prevalence differed greatly, with the highest rates in Mediterranean and Balkan countries. Carbapenemase-producing K pneumoniae isolates showed high resistance to last-line antibiotics. INTERPRETATION This initiative shows an encouraging commitment by all participants, and suggests that challenges in the establishment of a continent-wide enhanced sentinel surveillance for carbapenemase-producing Enterobacteriaeceae can be overcome. Strengthening infection control efforts in hospitals is crucial for controlling spread through local and national health care networks. FUNDING European Centre for Disease Prevention and Control.
Eurosurveillance | 2014
Hajo Grundmann; L. M. Schouls; David M. Aanensen; Gerlinde N. Pluister; Adriana Tami; Monika A. Chlebowicz; Corinna Glasner; Artur J. Sabat; K Weist; O. Heuer; Alexander W. Friedrich
Staphylococcus aureus is one of the most important human pathogens and meticillin-resistant S. aureus (MRSA) presents a major cause of healthcare- and community-acquired infections. This study investigated the spatial and temporal changes of S. aureus causing bacteraemia in Europe over a five-year interval and explored the possibility of integrating pathogen-based typing data with epidemiological and clinical information at a European level. Between January 2011 and July 2011, 350 laboratories serving 453 hospitals in 25 countries collected 3,753 isolates (meticillin-sensitive S. aureus (MSSA) and MRSA) from patients with S. aureus bloodstream infections. All isolates were sent to the national staphylococcal reference laboratories and characterised by quality-controlled spa typing. Data were uploaded to an interactive web-based mapping tool. A wide geographical distribution of spa types was found, with some prevalent in all European countries. MSSA was more diverse than MRSA. MRSA differed considerably between countries with major international clones expanding or receding when compared to a 2006 survey. We provide evidence that a network approach of decentralised typing and visualisation of aggregated data using an interactive mapping tool can provide important information on the dynamics of S. aureus populations such as early signalling of emerging strains, cross-border spread and importation by travel.
Journal of Investigative Dermatology | 2013
Magdalena M. van der Kooi-Pol; Corné P. de Vogel; Gerlinde N. Westerhout-Pluister; Yanka K. Veenstra-Kyuchukova; José C. Duipmans; Corinna Glasner; Girbe Buist; Goffe S. Elsinga; Hans Westra; Hendrik P.J. Bonarius; Herman Groen; Willem J. B. van Wamel; Hajo Grundmann; Marcel F. Jonkman; Jan Maarten van Dijl
Abbreviations: EB, epidermolysis bullosa; ET, exfoliative toxin; HlgB, gamma-hemolysin B; IsaA, immunodominant antigen A; Isd, iron-responsive surface determinant; Luk, leukocidin; LytM, peptidoglycan hydrolase; MFI, median fluorescence intensity; MLVA, multiple-locus variable number of tandem repeats analysis; Nuc, endonuclease; SAgs, superantigens; SasG, S. aureus surface protein G; SCIN, staphylococcal complement inhibitor; SE, staphylococcal enterotoxin
Microbial Genomics | 2016
Silvia Argimón; Khalil Abudahab; Richard J. E. Goater; Artemij Fedosejev; Jyothish Bhai; Corinna Glasner; Edward J. Feil; Matthew T. G. Holden; Corin Yeats; Hajo Grundmann; Brian G. Spratt; David M. Aanensen
Visualization is frequently used to aid our interpretation of complex datasets. Within microbial genomics, visualizing the relationships between multiple genomes as a tree provides a framework onto which associated data (geographical, temporal, phenotypic and epidemiological) are added to generate hypotheses and to explore the dynamics of the system under investigation. Selected static images are then used within publications to highlight the key findings to a wider audience. However, these images are a very inadequate way of exploring and interpreting the richness of the data. There is, therefore, a need for flexible, interactive software that presents the population genomic outputs and associated data in a user-friendly manner for a wide range of end users, from trained bioinformaticians to front-line epidemiologists and health workers. Here, we present Microreact, a web application for the easy visualization of datasets consisting of any combination of trees, geographical, temporal and associated metadata. Data files can be uploaded to Microreact directly via the web browser or by linking to their location (e.g. from Google Drive/Dropbox or via API), and an integrated visualization via trees, maps, timelines and tables provides interactive querying of the data. The visualization can be shared as a permanent web link among collaborators, or embedded within publications to enable readers to explore and download the data. Microreact can act as an end point for any tool or bioinformatic pipeline that ultimately generates a tree, and provides a simple, yet powerful, visualization method that will aid research and discovery and the open sharing of datasets.
Journal of Biological Chemistry | 2012
Carmine G. Monteferrante; Marcus Miethke; René van der Ploeg; Corinna Glasner; Jan Maarten van Dijl
Background: The Gram-positive bacterium Bacillus subtilis contains two twin-arginine (Tat) translocases, each specifically secreting one known substrate protein. Results: The TatAyCy translocase facilitates export of the metallophosphoesterase YkuE to the cell wall. Conclusion: YkuE is the third identified genuine Tat substrate in Bacillus. Significance: YkuE is the first protein found to be specifically targeted to a Gram-positive bacterial cell wall via the Tat pathway. The twin-arginine translocation (Tat) pathway is dedicated to the transport of fully folded proteins across the cytoplasmic membranes of many bacteria and the chloroplast thylakoidal membrane. Accordingly, Tat-dependently translocated proteins are known to be delivered to the periplasm of Gram-negative bacteria, the growth medium of Gram-positive bacteria, and the thylakoid lumen. Here, we present the first example of a protein, YkuE of Bacillus subtilis, that is specifically targeted by the Tat pathway to the cell wall of a Gram-positive bacterium. The cell wall binding of YkuE is facilitated by electrostatic interactions. Interestingly, under particular conditions, YkuE can also be targeted to the cell wall in a Tat-independent manner. The biological function of YkuE was so far unknown. Our present studies show that YkuE is a metal-dependent phosphoesterase that preferentially binds manganese and zinc.
PLOS Neglected Tropical Diseases | 2015
Nana Ama Amissah; Corinna Glasner; Anthony Ablordey; Caitlin S. Tetteh; Nana Konama Kotey; Isaac Prah; Tjip S. van der Werf; John W. A. Rossen; Jan Maarten van Dijl; Ymkje Stienstra
Background Buruli ulcer (BU) is a necrotizing skin disease caused by Mycobacterium ulcerans. Previous studies have shown that wounds of BU patients are colonized with M. ulcerans and several other microorganisms, including Staphylococcus aureus, which may interfere with wound healing. The present study was therefore aimed at investigating the diversity and topography of S. aureus colonizing BU patients during treatment. Methodology We investigated the presence, diversity, and spatio-temporal distribution of S. aureus in 30 confirmed BU patients from Ghana during treatment. S. aureus was isolated from nose and wound swabs, and by replica plating of wound dressings collected bi-weekly from patients. S. aureus isolates were characterized by multiple-locus variable number tandem repeat fingerprinting (MLVF) and spa-typing, and antibiotic susceptibility was tested. Principal Findings Nineteen (63%) of the 30 BU patients tested positive for S. aureus at least once during the sampling period, yielding 407 S. aureus isolates. Detailed analysis of 91 isolates grouped these isolates into 13 MLVF clusters and 13 spa-types. Five (26%) S. aureus-positive BU patients carried the same S. aureus genotype in their anterior nares and wounds. S. aureus isolates from the wounds of seven (37%) patients were distributed over two different MLVF clusters. Wounds of three (16%) patients were colonized with isolates belonging to two different genotypes at the same time, and five (26%) patients were colonized with different S. aureus types over time. Five (17%) of the 30 included BU patients tested positive for methicillin-resistant S. aureus (MRSA). Conclusion/Significance The present study showed that the wounds of many BU patients were contaminated with S. aureus, and that many BU patients from the different communities carried the same S. aureus genotype during treatment. This calls for improved wound care and hygiene.
PLOS ONE | 2015
Brandusa Elena Lixandru; Ani Ioana Cotar; Monica Straut; Codruta Usein; Dana Cristea; Simona Ciontea; Dorina Tatu-Chitoiu; Irina Codita; Alexandru Rafila; Maria Nica; Mariana Buzea; Anda Baicus; Mihaela Ghita; Irina Nistor; Cristina Tuchilus; Marina Indreas; Felicia Antohe; Corinna Glasner; Hajo Grundmann; Aftab Jasir; Maria Damian
This study presents the first characterization of carbapenem-non-susceptible Klebsiella pneumoniae isolates by means of a structured six-month survey performed in Romania as part of an Europe-wide investigation. Klebsiella pneumoniae clinical isolates from different anatomical sites were tested for antibiotic susceptibility by phenotypic methods and confirmed by PCR for the presence of four carbapenemase genes. Genome macrorestriction fingerprinting with XbaI was used to analyze the relatedness of carbapenemase-producing Klebsiella pneumoniae isolates collected from eight hospitals. Among 75 non-susceptible isolates, 65 were carbapenemase producers. The most frequently identified genotype was OXA-48 (n = 51 isolates), eight isolates were positive for bla NDM-1 gene, four had the bla KPC-2 gene, whereas two were positive for bla VIM-1. The analysis of PFGE profiles of OXA-48 and NDM-1 producing K. pneumoniae suggests inter-hospitals and regional transmission of epidemic clones. This study presents the first description of K. pneumoniae strains harbouring bla KPC-2 and bla VIM-1 genes in Romania. The results of this study highlight the urgent need for the strengthening of hospital infection control measures in Romania in order to curb the further spread of the antibiotic resistance.
Clinical Microbiology and Infection | 2015
Corinna Glasner; Gerlinde N. Pluister; Henrik Westh; Jan P. Arends; J. Empel; E. Giles; Frédéric Laurent; Franziska Layer; L. Marstein; Andreas Matussek; Alexander Mellmann; M. Pérez-Vásquez; E. Ungvári; Xiaomei Yan; Helena Žemličková; Hajo Grundmann; J.M. van Dijl
Methicillin-resistant Staphylococcus aureus (MRSA) belonging to the multilocus sequence type clonal complex 59 (MLST CC59) is the predominant community-associated MRSA clone in Asia. This clone, which is primarily linked with the spa type t437, has so far only been reported in low numbers among large epidemiological studies in Europe. Nevertheless, the overall numbers identified in some Northern European reference laboratories have increased during the past decade. To determine whether the S. aureus t437 clone is present in other European countries, and to assess its genetic diversity across Europe, we analysed 147 S. aureus t437 isolates from 11 European countries collected over a period of 11 years using multiple locus variable number tandem repeat fingerprinting/analysis (MLVF/MLVA) and MLST. Additionally 16 S. aureus t437 isolates from healthy carriers and patients from China were included. Most isolates were shown to be monophyletic with 98% of the isolates belonging to the single MLVA complex 621, to which nearly all included isolates from China also belonged. More importantly, all MLST-typed isolates belonged to CC59. Our study implies that the European S. aureus t437 population represents a genetically tight cluster, irrespective of the year, country and site of isolation. This underpins the view that S. aureus CC59 has been introduced into several European countries, not being restricted to particular geographical regions or specific host environments. The European S. aureus t437 isolates thus bear the general hallmarks of a high-risk clone.
International Journal of Medical Microbiology | 2013
Corinna Glasner; Artur J. Sabat; Monika A. Chlebowicz; Wannes Vanderhaeghen; Alexandra Fetsch; Beatriz Guerra; Helen Huber; Roger Stephan; Carmen Torres; Patrick Butaye; Andreas Voss; Mireille Wulf; Jan Maarten van Dijl
Methicillin-resistant Staphylococcus aureus sequence type 398 (MRSA ST398) has emerged in livestock worldwide. In particular, areas in Europe with high densities of livestock farming are affected. Consequently, the incidence of human colonization and infection with ST398 is rapidly increasing. Distinguishing different ST398 isolates with standard typing tools is problematic. The objective of this study was to examine the discriminatory power of Multiple-Locus Variable number tandem repeat Fingerprinting (MLVF) on a highly diverse ST398 collection. Our data show that MLVF combined with spa-typing is an attractive approach for high-resolution typing of ST398 isolates and unveiling their relatedness.